The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AMAG PHARMACEUTICALS INC | COM | 00163U106 | 15,699 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | ||
| ANIKA THERAPEUTICS INC | COM | 035255108 | 14,453 | 378,745 | SH | SOLE | 378,745 | 0 | 0 | ||
| ANTHEM INC | COM | 036752103 | 14,739 | 105,700 | SH | SOLE | 105,700 | 0 | 0 | ||
| CHARLES RIV LABS INTL INC | COM | 159864107 | 14,688 | 182,707 | SH | SOLE | 182,707 | 0 | 0 | ||
| FEI CO | COM | 30241L109 | 14,263 | 178,763 | SH | SOLE | 178,763 | 0 | 0 | ||
| GILEAD SCIENCES INC | COM | 375558103 | 23,203 | 229,300 | SH | SOLE | 229,300 | 0 | 0 | ||
| GNC HLDGS INC | COM CL A | 36191G107 | 25,473 | 821,190 | SH | SOLE | 821,190 | 0 | 0 | ||
| IMMUCELL CORP | COM PAR $0.10 | 452525306 | 945 | 125,292 | SH | SOLE | 125,292 | 0 | 0 | ||
| LIFEPOINT HEALTH INC | COM | 53219L109 | 27,410 | 373,430 | SH | SOLE | 373,430 | 0 | 0 | ||
| MAGELLAN HEALTH INC | COM NEW | 559079207 | 15,349 | 248,934 | SH | SOLE | 248,934 | 0 | 0 | ||
| SUPERNUS PHARMACEUTICALS INC | COM | 868459108 | 14,129 | 1,051,277 | SH | SOLE | 1,051,277 | 0 | 0 | ||
| SYMMETRY SURGICAL INC | COM | 87159G100 | 2,746 | 298,427 | SH | SOLE | 298,427 | 0 | 0 | ||
| TRIPLE-S MGMT CORP | CL B | 896749108 | 14,512 | 606,944 | SH | SOLE | 606,944 | 0 | 0 | ||
| VARIAN MED SYS INC | COM | 92220P105 | 14,867 | 184,000 | SH | SOLE | 184,000 | 0 | 0 | ||